Vaginal dilation treatment in women with vaginal hypoplasia: a prospective one-year follow-up study

OBJECTIVE: Vaginal dilation treatment has been shown to be a (cost) effective first-line alternative to surgery in normalizing vaginal length and improving sexual function in women with vaginal hypoplasia. There remains, however, a need for prospective studies, with long-term assessment of multiple outcomes. STUDY DESIGN: This was a prospective, single-centre observational study of 16 women with Mayer-Rokitansky-Kuster-Hauser syndrome (n = 12) or 46,XY disorders of sex development (n = 4). All women underwent an outpatient vaginal dilation program supervised by a psychologist and physiotherapist. At baseline (TO), stop of treatment (T1) and 1 year follow-up (T2), semistructured interviews, and validated questionnaires assessed sexual function and distress, self-esteem, vaginal perceptions, and health-related quality of life. Gynecological examinations evaluated vaginal dimensions. RESULTS: Ten women completed the program, 3 are still in the program, and dilation failed in 3 and chose vaginoplasty. Sixty-nine percent reached a normal vaginal length (>= 6.5 cm) in 5.8 +/- 3.3 months. Seventy percent were sexually active with pleasurable experiences at Ti, 57% at T2. The significant decrease in sexual distress at Ti (P = 6.5 cm) in 5.8 +/- 3.3 months. Seventy percent were sexually active with pleasurable experiences at Ti, 57% at T2. The significant decrease in sexual distress at Ti (P <.05) was followed by a nonsignificant increase at T2. Depressive mood symptomatology remained high at Ti and T2, related to loss of bodily integrity and fertility. The majority refused further psychological counseling. CONCLUSION: Vaginal dilation treatment should remain the cornerstone of treatment in women with vaginal hypoplasia. However, the diagnosis remains to have a negative impact on emotional well-being in the long term. The role of psychological intervention as both a primary and adjuvant treatment needs clear evaluation.A